Expectancy
Effects on Pain Measurements Identify a Subgroup of FM Patients that Report
Higher Levels of Symptomatology
D.J.
Clauw¹, F. Petzke, and R.H. Gracely²
Department of Medicine, Georgetown University Medical Center¹
and NIDR, National Institutes of Health, Bethesda², MD

INTRODUCTION:
Fibromyalgia is characterized by chronic widespread pain, tenderness and
increased sensitivity to various sensory stimuli. Some have suggested
that hypervigilance or increased “expectancy,” and not physiological factors,
may cause the change in somatosensory perception in this and related conditions.
One method of assessing the role of expectancy in sensory testing paradigms
is to present stimuli in both an ascending and random fashion. In ascending
paradigms, where the individual can anticipate the next stimulus, expectancy
is felt to play a role in symptom reporting, whereas this effect is eliminated
in random paradigms.
HYPOTHESIS:
The concurrent use of ascending and random testing paradigms will identify
some FM subjects who over-report pain in ascending paradigms (relative
to the value obtained in random testing), and these subjects will have
certain psychological and clinical characteristics.
PROCEDURES:
Pressure pain sensitivity was assessed in 42 patients with FM and 27 age
and gender matched HC. Both ascending (0.45-kg increments up to 4.54 kg
[ASC]) and random (7 stimuli repeated twice in random order [RAN] rectangular
pressure stimuli to the thumbnails of 5-sec duration were used. Pain intensity
(PI) was recorded with a combined numerical analog descriptor scale and
reported as area under curve. Tenderness (dolorimetry [DM], clinical pain
intensity (Short form McGill [MG]), depression (Beck depression inventory
[BDI] and symptom report (Brief Symptom Inventory [BSI]) were assessed
concurrently.
SUMMARY
OF RESULTS: As a group both HC and FM were more sensitive to the
random than to the ascending pressure stimuli (HC: 16.3±2.4 vs.
41.6±5.9 [±SEM], p<.0001 and FM: 52.5±5.0 vs. 72.0±4.6, p<0.0001).
The ratio of RAN/ASC was significantly lower in the group of FM
patients (1.64±0.2 vs. 3.78±0.8, p<.017) because of a subset
of subjects with high expectancy (ASC>RAN). The FM patients were divided
into two groups (RAN/ASC<1.1 = “high expectancy” [HE] and RAN/ASC>1.1
= “low expectancy [LE]). Only 9 (21%) had HE, and compared to the LE these
subjects reported significantly more clinical pain (MG scales: p<0.04-.001),
more tenderness (DM pain threshold: 1.07±0.13 vs. 1.5±.01, p<.012),
and higher somatic depression scores (BDI: 9.2±1.3 vs. 5.9±0.6,
p<.02). BSI scores were not significantly different between HE and
LE.
CONCLUSIONS:
An increased pain response to the ascending (relative to the random) testing
paradigm identifies a subgroup of FM patients with more severe disease,
and/or an increased tendency to report pain and/or symptoms. These findings
need to be extended and tested in the general population.
KEYWORDS:
Pain, sensory, psychological
Individuals performing this study
were supported in part by DAMD grants 17-96-1-6042 and 17-97-1-7361, and
the Veteran’s Administration. Presented
at the National Fibromyalgia Research Association's Subgroups in Fibromyalgia
Symposium, September 26-27, 1999, in Portland, Oregon.
National Fibromyalgia
Research Association
PO Box 500, Salem, OR 97302
|